HomeMarketsSharesUSANA Health Sciences Inc

Trade USANA Health Sciences Inc - USNA CFD

Market is not available at the momentMarket information is presented
as of 2026-11-19T20:46:52+00:00
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.09
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.02226 %
(-$1.11)

Trade size with leverage ~ $5,000.00

Money from leverage ~ $$4,000.00


-0.02226%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
0.00004 %
($0.00)

Trade size with leverage ~ $5,000.00

Money from leverage ~ $$4,000.00


0.00004%
Overnight funding adjustment time22:00 (UTC)
CurrencyUSD
Min traded quantity1
Margin20.00%
Stock exchangeUnited States of America
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close13.18
Open12.73
1-Year Change-31.85%
Day's Range12.72 - 13.25

Trade USANA Health Sciences Inc - USNA

About USANA Health Sciences, Inc.

USANA Health Sciences, Inc. develops and manufactures science-based nutritional and personal care products. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, Foods, Personal Care and Skincare and All Other. Its USANA Nutritionals Optimizers product line consists of supplements designed to meet individual health and nutritional needs. Its Essentials/CellSentials product line includes vitamin and mineral supplements that provides a total body nutrition for every age group beginning with children 13 months of age. Its Foods product line includes meal replacement shakes, snack bars, and other related products that provides macro-nutrition. Its Personal Care and Skincare product line includes its science-based personal care products and Celavive, its skincare system. Its All Other product line includes materials and online tools that are designed to assist its associates in building their businesses and in marketing its products.

Financial summary

BRIEF: For the fiscal year ended 01 January 2022, USANA Health Sciences, Inc. revenues increased 5% to $1.19B. Net income decreased 7% to $116.5M. Revenues reflect USANA® Nutritionals segment increase of 6% to $1.02B, USANA Foods segment increase of 5% to $83.1M, China segment increase of 6% to $563.5M, North Asia segment increase of 13% to $129.9M. Net income was offset by Associate incentives increase of 6% to $519.3M (expense), Selling/General/Admin.

Equity composition

Common Stock $.001 Par, 03/11, 50M auth., 15,843,837 o/s. Insiders control approx 53.74%. 1/93, spun-off from Gull Laboratories, Inc. 10/03, 8/98, 2-for-1 stock splits.

Latest shares articles

Take-Two heads into GTA VI launch with a weaker quarter and full-year outlook unchanged
Take-Two’s Q2 Net Bookings came in below guidance, but GTA VI pre-orders are at ‘unprecedented levels’. What the launch could mean for TTWO stock.
13:30, 19 November 2026
Nvidia results preview: what to expect from Q3 after the AI sell-off
Revenue guidance of USD 108bn, a new interim CEO and an AI sell-off: what investors are watching as Nvidia reports its fiscal Q3 2027 results.
12:06, 17 November 2026
What you need to know about Alphabet after the biggest one-day drop in its history – break-down
Google Cloud is growing fast, but AI spending pushed Alphabet’s free cash flow negative. A full break-down of results, valuation, debt and risks for GOOGL
11:53, 13 November 2026
Amazon's USD 220bn bet: how record AI spending could reshape the company
Amazon plans about USD 220bn of capex in 2026. We look at AWS, profitability, debt, valuation and the key catalysts and risks for AMZN shares.
10:50, 6 November 2026

User feedback and ratings

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready